SEC Form 4
Annovis Bio, Inc. (ANVS) insider trading
In the 12 months to Oct 24, 2026, 2 ANVS insiders reported open-market purchases of $4.3M across 8 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $4.3M
- 8 filings
Who traded ANVS, and when
- Purchase
ANVS daily close from Oct 24, 2025 to Oct 23, 2026, between $0.96 and $5.10, last $1.00. 0 sale and 8 purchase filings by 2 insiders, marked at their filing dates. Michael B. Hoffman, Director: bought $4.1M across 7 filings, first filed Nov 12, 2025, last May 21, 2026. Maria-Luisa Maccecchini, President & CEO: bought $200.0K across 1 filing, first filed Nov 12, 2025, last Nov 12, 2025.
Largest mark · tap a row for others
Michael B. Hoffman · Director
Filing 1 of 2 within a week · $2,031,650 total
Purchase $2,000,000
975,610 shares at $2.05 avg
Filed Nov 12, 2025 · traded Oct 28
Close on filing date $2.43
Michael B. Hoffman · Director
Director
$4.1M boughtMaria-Luisa Maccecchini · President & CEO
President & CEO
$200.0K boughtHas Annovis Bio, Inc.'s CEO sold stock?
No. Maria-Luisa Maccecchini (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
8 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Michael B. Hoffman | Director | — | $4.1M | 7 | — | |
| Maria-Luisa Maccecchini | President & CEO | — | $200.0K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Michael B. Hoffman Director | Purchase | 76,344 | $1.87 | $142.8K | 3,364,883 | |
traded | Michael B. Hoffman Director | Purchase | 713,800 | $2.10 | $1.5M | 3,288,539 | |
traded | Michael B. Hoffman Director | Purchase | 45,000 | $4.31 | $193.8K | 2,559,739 | |
traded | Michael B. Hoffman Director | Purchase | 39,200 | $4.08 | $159.9K | 2,529,739 | |
traded | Michael B. Hoffman Director | Purchase | 20,000 | $3.50 | $69.9K | 2,480,539 | |
traded | Michael B. Hoffman Director | Purchase | 15,000 | $2.11 | $31.6K | 2,470,539 | |
traded | Michael B. Hoffman Director | Purchase | 975,610 | $2.05 | $2.0M | 2,455,539 | |
traded | Maria-Luisa Maccecchini President & CEO | Purchase | 97,561 | $2.05 | $200.0K | 1,212,020 |
GET /stocks/filings/vX/form-4?tickers=ANVS&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"ANVS"
],
"issuer_cik": "0001477845",
"owner_cik": "0001290208",
"accession_number": "0001104659-26-065311",
"form_type": "4",
"filing_date": "2026-05-21",
"period_of_report": "2026-05-20",
"issuer_name": "Annovis Bio, Inc.",
"issuer_trading_symbol": "ANVS",
"owner_name": "Hoffman Michael B",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-05-20",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 18849,
"transaction_price_per_share": 1.8,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 3309950,
"transaction_value": 33928.200000000004,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"ANVS"
],
"issuer_cik": "0001477845",
"owner_cik": "0001290208",
"accession_number": "0001104659-26-065311",
"form_type": "4",
"filing_date": "2026-05-21",
"period_of_report": "2026-05-20",
"issuer_name": "Annovis Bio, Inc.",
"issuer_trading_symbol": "ANVS",
"owner_name": "Hoffman Michael B",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-05-20",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 2562,
"transaction_price_per_share": 1.75,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 3291101,
"transaction_value": 4483.5,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 1 record
- Option exercises1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ANVS every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.